13F
中

KNSA Kiniksa Pharmaceuticals International, plc

2026Q1 · CUSIP G52694109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
225
Δ holders QoQ
+2
Breadth percentile
Top 53%
Whale holders
119
Δ whales
+8
Inst. holding value
$2.2B
New positions
41
Closed positions
39
Price momentum (1Q)
—
Put / Call
3/4

Breadth history (34 quarters)

2024Q3: Δ+47 · h=174 2024Q4: Δ-16 · h=158 2025Q1: Δ+17 · h=175 2025Q2: Δ+12 · h=187 2025Q3: Δ+14 · h=201 2025Q4: Δ+22 · h=223 2026Q1: Δ+2 · h=225 2024Q3: holders=174 2024Q4: holders=158 2025Q1: holders=175 2025Q2: holders=187 2025Q3: holders=201 2025Q4: holders=223 2026Q1: holders=225 -47 -23.5 +0 +23.5 +47 142190237 24Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 2 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q1 Top 14% — —
2024Q3 Top 5% — —

Options Sentiment

Put holders
3
QoQ: 0
Call holders
4
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
68.4
EPS (TTM)
$0.91
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.29 2022-09-30: EPS 3.18 2022-12-31: EPS 0.07 2023-03-31: EPS -0.18 2023-06-30: EPS 0.21 2023-09-30: EPS -0.20 2023-12-31: EPS 0.37 2024-03-31: EPS -0.25 2024-06-30: EPS -0.06 2024-09-30: EPS -0.18 2024-12-31: EPS -0.11 2025-03-31: EPS 0.11 2025-06-30: EPS 0.23 2025-09-30: EPS 0.23 2025-12-31: EPS 0.18 2026-03-31: EPS 0.27 -0.32 1.59 3.50 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 88 2023-03-31: PE 4.92023-06-30: PE 52023-12-31: PE 99.72024-03-31: PE 152.12025-06-30: PE 667.62025-09-30: PE 87.72025-12-31: PE 60.52026-03-31: PE 62.1 4 353 701 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)